CET Trademark

Trademark Overview


On Friday, November 20, 2015, a trademark application was filed for CET with the United States Patent and Trademark Office. The USPTO has given the CET trademark a serial number of 86827821. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 24, 2023. This trademark is owned by Cumberland Pharmaceuticals Inc.. The CET trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

Leasing of office space

Business support, consulting, and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of individuals and companies to assist them with clinical research, clinical trials and applications for approval of pharmaceuticals and biomedical technologies; Advertising, marketing and promotion services; Administration and management of research grants

Development and research services in the fields of biomedical technologies and pharmaceuticals; Conducting research and clinical trials for others in the fields of biomedical technologies and pharmaceuticals; Consulting services in the fields of biomedical technologies and pharmaceuticals; Rental of laboratory apparatus and instruments; Leasing of laboratories containing laboratory equipment for scientific research and development of biomedical technologies and pharmaceuticals
cet

General Information


Serial Number86827821
Word MarkCET
Filing DateFriday, November 20, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 24, 2023
Registration Number5025713
Registration DateTuesday, August 23, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements


Pseudo MarkCUMBERLAND EMERGING TECHNOLOGIES
Goods and ServicesLeasing of office space
Goods and ServicesBusiness support, consulting, and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of individuals and companies to assist them with clinical research, clinical trials and applications for approval of pharmaceuticals and biomedical technologies; Advertising, marketing and promotion services; Administration and management of research grants
Goods and ServicesDevelopment and research services in the fields of biomedical technologies and pharmaceuticals; Conducting research and clinical trials for others in the fields of biomedical technologies and pharmaceuticals; Consulting services in the fields of biomedical technologies and pharmaceuticals; Rental of laboratory apparatus and instruments; Leasing of laboratories containing laboratory equipment for scientific research and development of biomedical technologies and pharmaceuticals

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code035
First Use Anywhere DateFriday, September 1, 2000
First Use In Commerce DateFriday, September 1, 2000

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code036
First Use Anywhere DateFriday, September 1, 2000
First Use In Commerce DateFriday, September 1, 2000

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code042
First Use Anywhere DateFriday, September 1, 2000
First Use In Commerce DateFriday, September 1, 2000

Trademark Owner History


Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events


Event DateEvent Description
Tuesday, November 24, 2015NEW APPLICATION ENTERED
Monday, May 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2015NOTICE OF PSEUDO MARK E-MAILED
Monday, March 14, 2016ASSIGNED TO EXAMINER
Thursday, March 17, 2016PRIORITY ACTION WRITTEN
Thursday, March 17, 2016PRIORITY ACTION E-MAILED
Thursday, March 17, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, April 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2016REGISTERED-PRINCIPAL REGISTER
Monday, August 23, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, January 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 24, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 23, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 24, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL